Some of the key players operating in the market include Thermo Fisher Scientific Inc., Eurofins Scientific, QIAGEN, WuXi AppTec, Promega Corporation, Abcam plc, Merck KGaA, PerkinElmer Inc., Enzo ...

The global miRNA sequencing and assay market size to grow from US$ 391.73 million in 2024, rise to US$ 443.95 million in 2025, and is expected to surpass US$ 1369.11 million by 2034. The market is ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

Southeast Asia stands at a pivotal moment in healthcare development. While the region represents 8.5 per cent of the world’s ...

Rising Demand for Genomic Research and Infectious Disease Diagnostics Drives Growth.Pune, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Proteinase K Market Size & Growth Analysis: According to SNS Insider, The ...

The global PD-L1 biomarker testing market is on a strong growth trajectory, rising from USD 777.2 million in 2025 to USD 1,690.8 million by 2035, at a CAGR of 8.1% during the forecast period.PD-L1 ...

The Global Rare Biomarkers Specimen Collection and Stabilization Market, valued at approximately USD 36.69 billion in 2023, is poised for significant growth, with an anticipated C ...

Smaller businesses such as biotech companies Abcam and GW Pharmaceuticals have also fled. A lack of new groups listing on the London Stock Exchange, a process known as an initial public offering ...

Stephen Wright has been watching some outstanding growth stocks falling recently. So is March the time for him to add them to ...

But there are lesser-known winners such as life science company Abcam, language translation specialist RWS and ID verification company GB Group. What should you do if you've held a share for more ...

After hours: 7:35:12 p.m. EST ...